<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://lipidbank.jp/mediawiki/index.php?action=history&amp;feed=atom&amp;title=LBF20406LT17</id>
	<title>LBF20406LT17 - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://lipidbank.jp/mediawiki/index.php?action=history&amp;feed=atom&amp;title=LBF20406LT17"/>
	<link rel="alternate" type="text/html" href="https://lipidbank.jp/mediawiki/index.php?title=LBF20406LT17&amp;action=history"/>
	<updated>2026-04-30T02:09:05Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.0</generator>
	<entry>
		<id>https://lipidbank.jp/mediawiki/index.php?title=LBF20406LT17&amp;diff=55909&amp;oldid=prev</id>
		<title>Editor: New page: {{Lipid/Header}}  {{Hierarchy|{{PAGENAME}}}}  {{Metabolite |LipidBank=XPR3401 |LipidMaps=LMFA03020002 |SysName=5S-Hydroxy-6R-S-cysteinyl- (trans-7,trans-9,cis-11,cis-14) -eicosatetraenoic ...</title>
		<link rel="alternate" type="text/html" href="https://lipidbank.jp/mediawiki/index.php?title=LBF20406LT17&amp;diff=55909&amp;oldid=prev"/>
		<updated>2011-02-21T04:59:31Z</updated>

		<summary type="html">&lt;p&gt;New page: {{Lipid/Header}}  {{Hierarchy|{{PAGENAME}}}}  {{Metabolite |LipidBank=XPR3401 |LipidMaps=LMFA03020002 |SysName=5S-Hydroxy-6R-S-cysteinyl- (trans-7,trans-9,cis-11,cis-14) -eicosatetraenoic ...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{Lipid/Header}}&lt;br /&gt;
&lt;br /&gt;
{{Hierarchy|{{PAGENAME}}}}&lt;br /&gt;
&lt;br /&gt;
{{Metabolite&lt;br /&gt;
|LipidBank=XPR3401&lt;br /&gt;
|LipidMaps=LMFA03020002&lt;br /&gt;
|SysName=5S-Hydroxy-6R-S-cysteinyl- (trans-7,trans-9,cis-11,cis-14) -eicosatetraenoic acid&lt;br /&gt;
|Common Name=&amp;amp;&amp;amp;Leukotriene E_4&amp;amp;&amp;amp;5S-Hydroxy-6R-S-cysteinyl- (7E,9E,11Z,14Z) -eicosatetraenoic acid&amp;amp;&amp;amp;&lt;br /&gt;
|Optical=DIMETHYL ESTER ; [ alpha ]^{20}_D =+35.2° [[Reference:Rosenberger_M:Newkom_C:Aig_ER:,J. Am. Chem. Soc.,1983,105,3656|{{RelationTable/GetFirstAuthor|Reference:Rosenberger_M:Newkom_C:Aig_ER:,J. Am. Chem. Soc.,1983,105,3656}}]]&lt;br /&gt;
|Solubility=METHANOL [[Reference:Rosenberger_M:Newkom_C:Aig_ER:,J. Am. Chem. Soc.,1983,105,3656|{{RelationTable/GetFirstAuthor|Reference:Rosenberger_M:Newkom_C:Aig_ER:,J. Am. Chem. Soc.,1983,105,3656}}]][[Reference:Cohen_N:Banner_BL:Lopresti_RJ:Wong_F:Rosenberger_M:Liu_YY:Thom_E:Liebman_AA:,J. Am. Chem. Soc.,1983,105,3661|{{RelationTable/GetFirstAuthor|Reference:Cohen_N:Banner_BL:Lopresti_RJ:Wong_F:Rosenberger_M:Liu_YY:Thom_E:Liebman_AA:,J. Am. Chem. Soc.,1983,105,3661}}]]&lt;br /&gt;
|UV Spectra=MONO-POTASSIUM SALT; lambda  = 270( epsilon  40000), 280( epsilon  49400), 291nm(  epsilon  40000) [[Reference:Cohen_N:Banner_BL:Lopresti_RJ:Wong_F:Rosenberger_M:Liu_YY:Thom_E:Liebman_AA:,J. Am. Chem. Soc.,1983,105,3661|{{RelationTable/GetFirstAuthor|Reference:Cohen_N:Banner_BL:Lopresti_RJ:Wong_F:Rosenberger_M:Liu_YY:Thom_E:Liebman_AA:,J. Am. Chem. Soc.,1983,105,3661}}]]&lt;br /&gt;
|NMR Spectra=DIMETHYL ESTER ; ^1 H-NMR(CDCl_3 ) :  delta  6.33(dd, J=14.5Hz, 10Hz, 1H, 10CH), 6.0(t, J=10Hz, 1H, 11-CH), 5.62(dd, J=14.4, 9.6Hz, 1H, 7-CH), 5.3(m, J=10,9Hz, 1H, 14-CH), 3.71 and 3.62(2S, 6H, OCH_3 ), 3.65(m, 1H, 5-CH), 3.4(m, 1H, 6-CH), 2.95(t, J=9Hz, 2H, 13-CH), 2.02(m, 2H, 16-CH), 0.86(t, J=6Hz, 3H, 20-CH) [[Reference:Rosenberger_M:Newkom_C:Aig_ER:,J. Am. Chem. Soc.,1983,105,3656|{{RelationTable/GetFirstAuthor|Reference:Rosenberger_M:Newkom_C:Aig_ER:,J. Am. Chem. Soc.,1983,105,3656}}]]&lt;br /&gt;
|Source=When leukotriene C4 was injected into male subjects, leukotriene E4 was found as a major urinary metabolite [[Reference:Orning_L:Kaijser_L:Hammarstrom_S:,Biochem. Biophys. Res. Commun.,1985,130,214|{{RelationTable/GetFirstAuthor|Reference:Orning_L:Kaijser_L:Hammarstrom_S:,Biochem. Biophys. Res. Commun.,1985,130,214}}]]. Incubation of leukotriene D4 with human polymorphonuclear leukocytes produced leukotriene E4 [[Reference:Lee_CW:Lewis_RA:Corey_EJ:Austen_KF:,Immunology,1983,48,27|{{RelationTable/GetFirstAuthor|Reference:Lee_CW:Lewis_RA:Corey_EJ:Austen_KF:,Immunology,1983,48,27}}]].&lt;br /&gt;
|Chemical Synthesis=[[Reference:Cohen_N:Banner_BL:Lopresti_RJ:Wong_F:Rosenberger_M:Liu_YY:Thom_E:Liebman_AA:,J. Am. Chem. Soc.,1983,105,3661|{{RelationTable/GetFirstAuthor|Reference:Cohen_N:Banner_BL:Lopresti_RJ:Wong_F:Rosenberger_M:Liu_YY:Thom_E:Liebman_AA:,J. Am. Chem. Soc.,1983,105,3661}}]] {{Image200|LBF20406SF04FT0001.gif}}&lt;br /&gt;
|Metabolism=Leukotriene D4 is converted to E4 by extracellular action of a dipeptidase released from granules of human polymorphonuclear leukocytes [[Reference:Lee_CW:Lewis_RA:Corey_EJ:Austen_KF:,Immunology,1983,48,27|{{RelationTable/GetFirstAuthor|Reference:Lee_CW:Lewis_RA:Corey_EJ:Austen_KF:,Immunology,1983,48,27}}]]. Leukotriene E4 is transformed to leukotriene F4 by  gamma -glultamyltransferase in the presence of glutathione, and to N-acetyl leukotriene E4 by incubation with rat liver microsomes [[Reference:Hammarstrom_S:Orning_L:Bernstrom_K:,Mol. Cell. Biochem.,1985,69,7|{{RelationTable/GetFirstAuthor|Reference:Hammarstrom_S:Orning_L:Bernstrom_K:,Mol. Cell. Biochem.,1985,69,7}}]].&lt;br /&gt;
|Symbol=LTE4&lt;br /&gt;
|Biological Activity=Leukotriene E4 stimulates airway smooth muscles from different animal species, and is less potent than C4 in contracting isolated guinea pig ileum [[Reference:Hammarstrom_S:,Annu. Rev. Biochem.,1983,52,355|{{RelationTable/GetFirstAuthor|Reference:Hammarstrom_S:,Annu. Rev. Biochem.,1983,52,355}}]].&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
{{Lipid/Footer}}&lt;/div&gt;</summary>
		<author><name>Editor</name></author>
	</entry>
</feed>